Multibagger Laurus Labs zooms 6 per cent, trades at fresh life-highs!

The stock made a fresh 52-week high for itself at Rs 605 per share, which apparently is its fresh life-high as well. 

Laurus Labs, one of the top-performing stocks of 2020, is back in the groove as it makes fresh life-highs for itself. The stock made a fresh 52-week high for itself at Rs 605 per share, which apparently is its fresh life-high as well. 

The stock gained almost 358 per cent in 2020 thereby, turning out to be one of the best multibaggers of 2020. After a stellar performance, the expectations from the counter remained subdued. Yet the stock is up by more than 70 per cent in 2021, so far. However, investors are gung-ho about the counter after studying its results, outlook, and the perception of quality leadership that puts Laurus Labs at a distinctive advantage. 

Pharma stocks have underperformed in 2021 on a relative basis even though few pharma companies continued to shine; thus, continuing its positive trend from 2020. Morepen Laboratories is one such pharma stock that has doubled in value this year while Divi’s Laboratories is outperforming markets along with Laurus Labs. 

Laurus Labs is gaining due to its focus on growth areas such as APIs, FDFs, ingredients, and synthesis. The company is reaping rich dividends of its research and R&D spends in the early stages.